ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $520,000 | -74.1% | 11,219 | -86.3% | 0.00% | -71.4% |
| Q1 2019 | $2,006,000 | +1130.7% | 82,175 | +661.7% | 0.01% | +600.0% |
| Q4 2018 | $163,000 | -3.6% | 10,788 | -0.9% | 0.00% | 0.0% |
| Q3 2018 | $169,000 | -65.9% | 10,890 | -63.2% | 0.00% | -50.0% |
| Q2 2018 | $496,000 | +102.4% | 29,582 | +96.7% | 0.00% | +100.0% |
| Q1 2018 | $245,000 | -15.5% | 15,037 | -76.4% | 0.00% | -66.7% |
| Q3 2015 | $290,000 | – | 63,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
| Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
| First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
| Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
| KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
| Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
| EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
| Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |